Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP, São Paulo and CHC/UFPR in Curitiba, Brazil, examines how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
This on-demand webinar was originally broadcast on June 9, 2026.
What should you expect to learn from this webinar?
• Understand the mechanisms of graft-versus-host allorecognition following HCT and its role in leukemia immune escape.
• Review the methodologies used to assess HLA loss of heterozygosity (LOH).
• Discuss current clinical HCT data on LOH and its impact on donor selection for a second HCT.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY.
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Devyser.